The Department of Health Policy and Management (HPM) has a rich history of educating individuals for careers in health policy and management since its inception in 1950. Our strengths include the areas of health system governance and management, long-term care, Medicare and Medicaid policy, pharmaceutical policy, mathematical modeling and simulation, and health economics.

We prepare students in our MPH (and JD/MPH) programs to develop and advocate for public policies, create policy regulation, and work in governmental and public health sectors. Our MHA (and MHA-MBA) are prepared to fill key leadership positions in health care systems, hospitals, health insurance firms, consulting firms, physician groups, long-term care, and many other health-related organizations. As successful health care system executives these graduates provide leadership and are skilled in the management, financing and delivery of services, technological innovations, health policy and regulatory requirements, and public health and disease prevention strategies.

Students in our research-focused MS and PHD programs develop the rigorous analytical and quantitative skills needed for careers in top academic settings, government, and industry.

Maximize Find a research program for your interests

Maximize Pursue a career in health policy and management

Maximize HPM Academic Programs

 

Hernandez says experimental medicines for COVID-19 could help someday, but home runs not guaranteed

WBHM - This proof-of concept ...
Hernandez says experimental medicines for COVID-19 could help someday, but home runs not guaranteed

WBHM - This proof-of concept study suggests that the strategy of blocking virus with antibodies holds promise. Inmaculada “Inma” Hernandez (HPM ’16), Pitt School of Pharmacy, is hopeful, but she doubts that these drugs will be a game-changer. “These drugs are so complex to produce, probably we will... (09/18/2020)

Jalal research shows fatal overdoses in U.S. rebounded in 2019

TRIBUNE-DEMOCRAT – “We are co...
Jalal research shows fatal overdoses in U.S. rebounded in 2019

TRIBUNE-DEMOCRAT – “We are concerned that policymakers may have interpreted the one-year downturn in 2018 as evidence for an especially effective national response or the start of a long-term trend,” said lead author Hawre Jalal, HPM. “Unfortunately, that isn’t supported by the data.” The data sugg... (09/17/2020)

Roberts on COVID-19 in Pittsburgh: A timeline of the first six months

PITTSBURGH POST-GAZETTE - "We...
Roberts on COVID-19 in Pittsburgh: A timeline of the first six months

PITTSBURGH POST-GAZETTE - "We had a pretty good early run," said HPM Chair Mark Roberts, director of the Public Health Dynamics Lab. "If you look at the graph of cases over time, back in April, we were doing pretty well with surprisingly few cases." The peak day of the early months of COVID-19 came... (09/16/2020)

Hershey on how courts may reconsider temporary coronavirus restrictions as pandemic drags on

WASHINGTON POST – HPM's Tina ...
Hershey on how courts may reconsider temporary coronavirus restrictions as pandemic drags on

WASHINGTON POST – HPM's Tina Batra Hershey agrees that there's a need for executive administrations to “provide clear and transparent communications about what they’re doing, to ensure that there is a tailored response.” That might mean articulating what steps will be taken to measure whether restr... (09/16/2020)

Steroids can save lives among COVID-19 patients, UPMC and Pitt researchers say

NPR – Pitt Medical Center’s D...
Steroids can save lives among COVID-19 patients, UPMC and Pitt researchers say

NPR – Pitt Medical Center’s Derek Angus (BCHS ’92) said that while some worried that steroids could also prevent the body from fighting off the coronavirus, all the coordinated studies reached the same conclusion, which is, I guess we have to stop our trials. It is reassuring that we can get random... (09/02/2020)